Peter Salgo, MD, notes that the patient adherence rate to therapy for type 2 diabetes mellitus (T2DM) is less than 60 percent. Dr Salgo states that weight loss has been associated with improvement in adherence rate to T2DM therapy, as demonstrated by the SHIELD study. Dr Salgo and Maria Lopes, MD, MS, comment that short-term weight loss success can be a powerful motivator.
Dr Lopes remarks that although weight loss can help keep patients focused, support from the team of healthcare professionals involved in a patient’s care is also important. Dr Lopes comments that patient-centered approaches are effective, and innovative health information technology tools have been developed to help reach patients.
Kari Uusinarkaus, MD, FAAFP, FNLA, discusses the strategies that Colorado Springs Health Partners has implemented to help improve patient adherence, and Jeffrey D. Dunn, PharmD, MBA, describes managed care’s unique position when addressing adherence issues in T2DM.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More
Makers of medical tests will have about 4 years to show the FDA that their new offerings deliver accurate results; after previously decreasing for 27 years, US tuberculosis (TB) cases increased every year since 2020; a US district judge rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to the Medicare drug price negotiation program.
Read More